Finally, one must consider the possibility that the increase in CD44 surface expression, MMP-9 activation, and the migration of prostate cancer cells may occur through multiple down stream signaling pathways that are instigated by αvβ3 receptor. The gene discussed is CD44; the disease is prostate carcinoma.